International Journal of Chemotherapy Research and Practice

Aims and Scope

International Journal of Chemotherapy Research and Practice (IJCP) is an open-access, peer-reviewed journal dedicated to advancing the field of chemotherapy. Focused on the development, application, and clinical practice of chemotherapy treatments, the journal publishes cutting-edge research in areas such as drug development, pharmacokinetics, drug interactions, and patient outcomes.
 

Scope & Focus Areas:

• Chemotherapy Drug Development: Discovery, formulation, and testing of new chemotherapeutic agents aimed at improving treatment efficacy.
• Pharmacokinetics & Pharmacodynamics: Understanding how chemotherapy drugs are absorbed, metabolized, and excreted to optimize drug effectiveness and patient safety.
• Chemotherapy in Disease Management: Exploring the role of chemotherapy in the treatment of cancer, infections, autoimmune disorders, and other diseases.
• Chemotherapy Side Effects & Management: Research focused on managing adverse effects of chemotherapy and improving the quality of life for patients undergoing treatment.
• Clinical Trials & Patient Outcomes: Reporting clinical trial results and outcomes from chemotherapy treatments, emphasizing evidence-based practices.
• Biomarker Identification: Identifying biomarkers to improve chemotherapy effectiveness, personalize treatment, and reduce toxicity.
• Drug Interactions: Investigating potential interactions between chemotherapy drugs and other medications to enhance therapeutic efficacy and patient safety.
• Novel Approaches: Exploring innovative strategies, including personalized medicine and combination therapies, to optimize chemotherapy treatments.
• Combination Therapy: Exploring the potential of combining chemotherapy with other modalities, such as immunotherapy, targeted therapy, and radiation therapy.
• Economic and Health Policy Implications: Studying the economic impact of chemotherapy treatments and their integration into health policy and clinical practice guidelines.

Few keywords are specified, which belong to the scope of the journal but not strictly restricted to them.

• Breast cancer
• Cancer
• Lung cancer
• Electrochemotherapy
• Chemotherapy resistance
• Antimicrobial chemotherapy
• Antifungal therapy
• Colorectal cancer
• Anticancer therapy
• Personalized chemotherapy
• Precision chemotherapy
• Cervical carcinoma
• Targeted therapies
• Gene therapy
• Antiviral therapy
• Chemoradiotherapy
• Chemoresistance
• Chemotherapy regimens
• Antibacterial therapy
• Antiparasitic therapy
• Chemotherapy for cancer treatment
• Antibiotic resistance
• Cancer therapy
• Chemotherapy side effects
• Chemoprevention
• Drug discovery
• Antimicrobial agents
• Clinical trials
• Pharmacology
• Drug delivery systems
• Nanoparticles for drug delivery
• Anticancer agents
• Drug resistance mechanisms
• Multi-drug resistance
• Biomarkers for chemotherapy response
• Cancer stem cells
• Chemotherapeutic agents for rare diseases
• New chemotherapy drugs
• Combinatorial chemotherapy
• Drug toxicity
• Chemotherapy Research in Artificial Intelligence
• Chemotherapy-induced peripheral neuropathy
• Chemotherapy for breast cancer
• Chemotherapy for lung cancer
• Chemotherapy for leukemia
• Chemotherapy for lymphoma
• Chemotherapy for sarcoma
• Chemotherapy for gastrointestinal tumors
• Chemotherapy for ovarian cancer
• Chemotherapy for pancreatic cancer
• Chemotherapy for brain tumors
• Chemotherapy for pediatric cancers
• Chemotherapy for melanoma
• Chemotherapy for prostate cancer
• Chemotherapy for bladder cancer
• Chemotherapy for head and neck cancers
• Chemotherapy for esophageal cancer
• Chemotherapy for thyroid cancer
• Chemotherapy for testicular cancer
• Chemotherapy for cervical cancer
• Chemotherapy for endometrial cancer
• Chemotherapy for liver cancer
• Chemotherapy for kidney cancer
• Chemotherapy for multiple myeloma